Poor sleep linked to worse fatigue and function in MS patients
NCT ID NCT07374237
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 102 people with multiple sclerosis to see how sleep quality relates to fatigue, body awareness, and arm and leg function. Participants were grouped by good or poor sleep, and their abilities were measured with tests like walking speed and a heartbeat counting task. The goal was to understand how sleep problems might worsen MS symptoms and daily functioning.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
102 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of individuals diagnosed with multiple sclerosis (MS) by a specialist physician. Eligible participants are adults aged 18-65 years, with an Expanded Disability Status Scale (EDSS) score between 1.0 and 5.0, who have not experienced an MS relapse within the past three months. Participants must be able to stand independently for at least 60 seconds without assistive devices and have sufficient cognitive function, defined as a Mini-Mental State Examination score greater than 24. Exclusion criteria include other neurological, visual, or circulatory conditions affecting balance, recent corticosteroid use, pregnancy, significant orthopedic or spinal disorders, and recent medication changes. Written informed consent is obtained from all participants prior to enrollment.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with multiple sclerosis by a specialist physician * Aged between 18 and 65 years * No MS relapse within the last 3 months * Expanded Disability Status Scale (EDSS) score between 1.0 and 5.0 * Ability to stand independently for at least 60 seconds without the use of any assistive device * No additional neurological disorder or circulatory/visual impairment that may affect balance * Cognitive function score \>24 on the Mini-Mental State Examination (MMSE) * Provided written informed consent after receiving detailed information about the study Exclusion Criteria: * Use of corticosteroids within the last 4 weeks * Pregnancy * Presence of spinal deformities, disc herniation, or other spinal pathologies * Presence of orthopedic conditions affecting the hip, knee, or ankle * History of surgery involving the spine, hip, knee, or ankle * Change in medication within the last month
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ankara Bilkent City Hospital
Ankara, Çankaya, 06000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise rebuild muscle and balance in MS?
- Can diet ease the crushing fatigue of multiple sclerosis?
- One-Time CAR-T infusion tested against progressive MS
- Can PET scans reveal hidden brain inflammation in MS?
- Can a pill rebuild the Brain's insulation? MS trial puts remyelination to the test
- Migraines and tension headaches may be hidden companions to multiple sclerosis